Rosetta Genomics (Rosetta Genomics) EV-to-Revenue : 0.00 (As of May. 25, 2024)

Rosetta Genomics EV-to-Revenue Chart

Rosetta Genomics Annual Data
	Trend	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16
EV-to-Revenue		Get a 7-Day Free Trial					56.31	34.07	24.12	1.55	0.95

Rosetta Genomics Quarterly Data
	Dec10	Mar11	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17
EV-to-Revenue	Get a 7-Day Free Trial															1.03	1.79	1.37	0.95	1.42

Competitive Comparison of Rosetta Genomics's EV-to-Revenue

For the Diagnostics & Research subindustry, Rosetta Genomics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rosetta Genomics's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rosetta Genomics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Rosetta Genomics's EV-to-Revenue falls into.

Rosetta Genomics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Rosetta Genomics's EV-to-Revenue for today is calculated as:

Rosetta Genomics's current Enterprise Value is $0.00 Mil.
Rosetta Genomics's Revenue for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rosetta Genomics  (OTCPK:ROSGQ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Rosetta Genomics's PS Ratiofor today is calculated as:

Rosetta Genomics's share price for today is $0.0001.
Rosetta Genomics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.70.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rosetta Genomics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Rosetta Genomics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Rosetta Genomics (Rosetta Genomics) Business Description